 |
|
|
|
 |
|
|
|
| Article 1 to 8 out of 8 concerning Medical Research Council (MRC)
|
-
Jan Löwe awarded 2007 EMBO Gold Medal
(08/02/2007)
Researcher revolutionised understanding of the bacterial cytoskeleton
Jan Löwe of the Medical Research Council's Laboratory of Molecular Biology (MRC-LMB, Cambridge, UK) has been chosen as the 2007 winner of the EMBO Gold Medal. Jan was selected for the award "in recognition of his landmark work elucidating the ...
-
Organon and MRC Technology sign antibody development agreement
(07/26/2007)
Organon, the human healthcare business unit of Akzo Nobel, together with MRC Technology announced that they have signed a collaborative agreement to develop a humanized antibody for the treatment of certain forms of cancer. The Therapeutic Antibody ...
-
MorphoSys's AbD Serotec Expands Antibody License Agreement with Medical Research Council
(03/21/2007)
MorphoSys AG announced that its business unit AbD Serotec has significantly expanded its license agreement with MRC Technology (MRCT), the technology transfer arm of Great Britain's Medical Research Council (MRC). The agreement, which provides AbD ...
-
VASTox joins European research consortium to target the development of new treatments for cancer
(01/19/2007)
Research will focus on Cancer Stem Cells as target for new therapies
VASTox announced that it has become a partner in a new European consortium that will undertake research towards developing new treatments for cancer. The research programme, called Targeting Cancer Stem Cells for Therapy, will be backed by a EUR2 ...
-
The Medical Research Council and GATC Biotech sign Sequencing Contract
(05/30/2006)
The Medical Research Council (MRC) and GATC Biotech have signed a mutual contract relating to the provision of services for DNA sequencing. GATC Biotech is a tender winner selected from over ten participating suppliers for the MRC sequencing ...
-
Scientists unlock more secrets of HIV and SARS
(05/16/2006)
UK scientists have cracked one of the key biological processes used by viruses such as HIV and SARS when they replicate according to a paper published in the journal Nature. Viruses are able to interfere with the host cell processes that our bodies ...
-
Oxford University researchers and local company work together to accelerate HIV vaccine research
(06/17/2005)
Scientists in Oxford, developing a vaccine for HIV, hope to be able to accelerate the testing of the vaccine thanks to a donation of vital research reagents by a local Oxford company. ProImmune Ltd has donated reagents based on its Pro5® MHC ...
-
Genomics specialist Geneservice announces management buyout from the Medical Research Council
(06/08/2005)
The current management of genomics specialist MRC geneservice announced it had reached agreement with the UK MRC over a management buyout. The assets and majority of staff of MRC geneservice will be transferred into a new company Geneservice Ltd on ...
|
|
|
Top